[Noradrenaline-antagonistic effects of some phenylethylamine and phenoxyethylamine derivatives].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003655:Decerebrate State; D006221:Halothane / Q000494:pharmacology; D006900:Hydroxylation; D007659:Ketones / Q000494:pharmacology; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D000317:Adrenergic alpha-Antagonists; D007659:Ketones; D008738:Methyl Ethers; D009281:Naphthalenes; D010627:Phenethylamines; D006221:Halothane; D009638:Norepinephrine
Noradrenalin-antagonistische Wirkung verschiedener Phenylaethylamin- und Phenoxyaethylamin-Derivate.